Pronađeno: 11-20 / 165 radova

Autori: Bila Jelena S

>> Filter: Samo Article i Review

Naslov High NK cell counts at day 90 predict improved survival in event-free patients after T-cell depleted allogeneic stem cell transplantation (Article)
Autori Pesic Andrej  Besevic Nevena  ...  Stanisavljevic Dejana M  Kraguljac-Kurtovic Nada  Bukumiric Zoran M  Kecman Natalija  Lemajic Nikola  Smiljanic Mihailo  Suvajdzic-Vukovic Nada D  Bogdanovic Andrija D  Vidovic Ana D  Bila Jelena S  Mitrovic Mirjana M  Lekovic Danijela R  Virijevic Marijana  Djunic Irena S  Antic Darko A  Todorovic-Balint Milena R 
Info FRONTIERS IN IMMUNOLOGY, (2025), vol. 16 br. , str. -
Projekat Ministry of Science, Technological Development and Innovation [451-03-65/2024-03/200110]
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa  
Naslov Disease Characteristics and Treatment Outcomes of Myeloma Patients Under 50 Years of Age: An Analysis of the Balkan Myeloma Study Group (Article)
Autori Fotiou Despina  ...  Bila Jelena S  ...  Sretenovic Aleksandra M  Markovic Olivera B  ...  Cvetkovic Zorica P  ...  (broj koautora 23) 
Info CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, (2025), vol. 25 br. 5, str. e310-e318
Projekat Sanofi
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa  
Naslov VCd versus VRd in Newly Diagnosed Multiple Myeloma: Matched Real-World Analysis from the Balkan Myeloma Study Group (BMSG) (Article)
Autori Kastritis Efstathios  ...  Bila Jelena S  ...  Cvetkovic Zorica P  Markovic Olivera B  ...  Sretenovic Aleksandra M  ...  (broj koautora 24) 
Info CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, (2025), vol. 25 br. 2, str. E71-E81
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa  
Naslov Managing novel therapies and concomitant medications in chronic lymphocytic leukemia: key challenges (Review)
Autori Kozarac Sofija  Ivanovic Jelena  Mitrovic Marko  Tomic-Vujovic Kristina  Arsenovic Isidora  Suvajdzic-Vukovic Nada D  Bogdanovic Andrija D  Vidovic Ana D  Todorovic-Balint Milena R  Bila Jelena S  Mitrovic Mirjana M  Lekovic Danijela R  Djunic Irena S  Virijevic Marijana  Trivic Aleksandar S  Micic Jelena D  Antic Darko A 
Info FRONTIERS IN PHARMACOLOGY, (2025), vol. 15 br. , str. -
Projekat Ministry of Science, Technological Development and Innovation [451-03-65/2024-03/200110]
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa  
Naslov Phase 3 Study of Teclistamab (Tec) in Combination with Lenalidomide (Len) and Tec Alone Versus Len Alone in Newly Diagnosed Multiple Myeloma (NDMM) As Maintenance Therapy Following Autologous Stem Cell Transplantation (ASCT): Safety Run-in (SRI) Results from the Majestec-4/EMN30 Trial (Meeting Abstract)
Autori Zamagni Elena  ...  Bila Jelena S  ...  (broj koautora 53) 
Info BLOOD, (2024), vol. 144 br. , Suppl. 1, str. 495-498
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa  
Naslov Risk Factors for Venous Thromboembolism in Acute Promyelocytic Leukemia (Article)
Autori Sabljic Nikica  Pantic Nikola M  Virijevic Marijana  Rajic Jovan  Cvetkovic Mirjana  Trajkovic Lazar  Pravdic Zlatko  Bukumiric Zoran M  Suvajdzic-Vukovic Nada D  Bogdanovic Andrija D  Vidovic Ana D  Todorovic-Balint Milena R  Bila Jelena S  Lekovic Danijela R  Djunic Irena S  Antic Darko A  Mitrovic Mirjana M 
Info CANCERS, (2024), vol. 16 br. 24, str. -
Projekat Ministry of Science, Technological Development and Innovation of the Republic of Serbia; [451-03-65/2004-03/200110]
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa  
Naslov Does Double Mean Trouble? Coexistence of Myeloproliferative and Lymphoproliferative Neoplasms (Article)
Autori Lekovic Danijela R  Ivanovic Jelena  Terzic Tatjana T  Perunicic-Jovanovic Maja D  Dencic-Fekete Marija  Jovanovic Jelica V  Arsenovic Isidora  Vukovic Vojin M  Bila Jelena S  Bogdanovic Andrija D  Antic Darko A 
Info JOURNAL OF CLINICAL MEDICINE, (2024), vol. 13 br. 6, str. -
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa  
Naslov Efficacy and safety of melflufen plus daratumumab and dexamethasone in relapsed/refractory multiple myeloma: results from the randomized, open-label, phase III LIGHTHOUSE study (Article)
Autori Pour Ludek  ...  Bila Jelena S  ...  (broj koautora 16) 
Info HAEMATOLOGICA, (2024), vol. 109 br. 3, str. 895-905
Projekat [NCT04649060]
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa  
Naslov Bortezomib-Cyclophosphamide-Dexamethasone (VCD) Vs Bortezomib-LenalidomideDexamethasone (VRD) in Newly Diagnosed Multiple Myeloma: A Matched Real-World Analysis from the Balkan Myeloma Study Group (BMSG) (Meeting Abstract)
Autori Kastritis Efstathios  ...  Bila Jelena S  ...  Cvetkovic Zorica P  Markovic Olivera B  ...  Sretenovic Aleksandra M  ...  (broj koautora 20) 
Info BLOOD, (2023), vol. 142 br. , Suppl. 1, str. -
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa  
Naslov Subcutaneous daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone in patients with relapsed or refractory multiple myeloma (APOLLO): extended follow up of an open-label, randomised, multicentre, phase 3trial (Article)
Autori Dimopoulos Meletios Athanasios  ...  Bila Jelena S  ...  (broj koautora 21) 
Info LANCET HAEMATOLOGY, (2023), vol. 10 br. 10, str. E813-E824
Projekat European Myeloma Network; Janssen Research Development
Ispravka ISI/Web of Science   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Ispis zapisa u formatu:TXT | BibTeX